captopril has been researched along with methyldopa in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 32 (55.17) | 18.7374 |
1990's | 11 (18.97) | 18.2507 |
2000's | 6 (10.34) | 29.6817 |
2010's | 9 (15.52) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Elghozi, JL; Grünfeld, JP; Meyer, P | 1 |
Croog, SH; Jenkins, CD; Lee, D; Levine, S; Mendes de Leon, CF; Sudilovsky, A | 1 |
Herlitz, H | 1 |
Crawford, GA; Gallery, ED; Györy, AZ; Kelly, D | 1 |
Cowie, RL; Dansey, RD | 1 |
Baume, RM; Croog, SH; Levine, S; Schoenberger, JA; Sudilovsky, A | 1 |
Ram, CV | 1 |
Cerný, J; Dolezel, S; Dostál, M; Guba, P; Petrzilka, J; Sotolová, O; Urbánek, P; Vasků, A; Vasků, J | 1 |
Cerný, J; Dostál, M; Gregor, Z; Guba, P; Rebícek, J; Sotolová, O; Urbánek, P; Vasků, A; Vasků, J | 1 |
Durando, C; Gessa, M; Leidi, L; Maina, G; Margaria, E; Medaglia, M | 1 |
Moser, M | 1 |
Bhatnagar, D; Henkel, TW; Johnson, A; Thind, GS | 1 |
Bulpitt, CJ; Fletcher, AE; Hill, JF | 1 |
Baume, RM; Clive, J; Croog, SH; Levine, S; Sudilovsky, A | 1 |
Williams, GH | 1 |
Croog, SH; Levine, S; Sudilovsky, A; Testa, MA | 1 |
Cervenka, J; O'Connor, DT; Parmer, RJ; Saltman, P; Strause, L | 1 |
Brown, B; Bulpitt, CJ; Croog, SH; Jenkins, CD; Klerman, GL; Levine, S; Testa, MA; Williams, GH | 1 |
Oke, VG; Patel, K; Raghu, CN; Shah, BP | 1 |
Dadkar, VN; Damle, VB; Jaguste, VS; Khokhani, RC; Oke, VG; Patel, K; Raghu, CN; Tahiliani, R | 1 |
Rakel, RE | 1 |
Kaneko, Y; Sesoko, S | 1 |
Alfiero, R; Padula, A; Rizzo, A; Russo, L; Strozzi, C | 1 |
Conway, J | 1 |
Garrido Peralta, M; Gras, X; Ocón, J; Oliván, J; Rodicio, JL; Rodríguez Alvarez, J; Ruilope, L; Seco Vasco, J | 1 |
Alfiero, R; Cocco, G; Padula, A; Portaluppi, F; Rizzo, A; Strozzi, C; Tasini, MT; Urso, L | 1 |
Kramsch, DM; Kulaga, SF; Walker, JF | 1 |
Scapellato, L; Stornello, M | 1 |
Marxer, A; Schier, O | 1 |
Koller, H; Prager, H | 1 |
Wallin, JD | 1 |
Finnerty, FA | 1 |
Zabetakis, PM | 1 |
Chernow, B; Coleman, MD; Lake, CR; Zaloga, GP; Ziegler, MG | 1 |
Moyer, JH | 1 |
Fasano, ML; Ferrara, LA; Iannuzzi, A; Rubba, P | 1 |
Cervoni, P; Chan, PS; Ronsberg, MA | 1 |
Abassi, ZA; Cuda, G; Golomb, E; Keiser, HR; Panchal, VR; Stylianou, M; Trachewsky, D | 1 |
Corrêa, FM; Lebrun, FL; Lebrun, I | 1 |
Currie, D; McDevitt, DG; Nicholson, AN; Wright, NA; Zetlein, MB | 1 |
Amir, M; Bar-On, D; Cristal, N; Loidl, A | 1 |
Cristal, N; Yodfat, Y | 1 |
Amir, M; Bar-On, D; Cristal, N; Yodfat, Y | 1 |
7 review(s) available for captopril and methyldopa
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
ACE-inhibitors and quality of life.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Enalapril; Health Status; Humans; Hypertension; Methyldopa; Middle Aged; Oxprenolol; Quality of Life | 1990 |
Calcium antagonists in the treatment of hypertension.
Topics: Biological Transport, Active; Calcium; Calcium Channel Blockers; Captopril; Diltiazem; Diuretics; Drug Resistance; Drug Therapy, Combination; Electrophysiology; Humans; Hypertension; Hypertension, Renovascular; Ion Channels; Kinetics; Methyldopa; Muscle, Smooth, Vascular; Nifedipine; Propranolol; Sodium; Vascular Resistance; Verapamil | 1985 |
[Bases of pharmacological therapy of essential hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Antihypertensive Agents; Captopril; Clonidine; Diuretics; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Minoxidil; Monoamine Oxidase Inhibitors; Prazosin; Secologanin Tryptamine Alkaloids | 1980 |
Antihypertensive agents 1969-1980.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Clonidine; Ergolines; Fusaric Acid; Guanidines; Humans; Hydralazine; Indoramin; Methyldopa; Minoxidil; Nifedipine; Piperazines; Prazosin; Prostaglandins | 1981 |
Profiling the hypertensive patient in sports.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Captopril; Clonidine; Diuretics; Exercise Test; Exercise Therapy; Female; Humans; Hypertension; Male; Methyldopa; Physical Examination; Physical Exertion; Physical Fitness; Renin-Angiotensin System; Reserpine; Sports; Vasodilator Agents | 1984 |
Drug systems approach to hypertension.
Topics: Captopril; Clonidine; Drug Combinations; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Hypertension, Malignant; Methyldopa; Patient Compliance; Prazosin; Proteinuria; Renin-Angiotensin System; Reserpine; Spironolactone | 1984 |
20 trial(s) available for captopril and methyldopa
Article | Year |
---|---|
Relation of hostility to medication adherence, symptom complaints, and blood pressure reduction in a clinical field trial of antihypertensive medication.
Topics: Adult; Anger; Antihypertensive Agents; Blood Pressure; Captopril; Hostility; Humans; Hypertension; Male; Methyldopa; Middle Aged; Patient Compliance; Personality Inventory; Propranolol; Quality of Life; Sick Role | 1992 |
Captopril in hypertensive black men in southern Africa.
Topics: Captopril; Drug Evaluation; Drug Therapy, Combination; Humans; Hypertension; Male; Methyldopa; Prazosin | 1990 |
Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group.
Topics: Adult; Age Factors; Aged; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Educational Status; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Multicenter Studies as Topic; Propranolol; Quality of Life; Random Allocation; United States | 1990 |
A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate-to-severe essential hypertension.
Topics: Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Proline; Pulse; Random Allocation | 1985 |
Angiotensin converting enzyme inhibitors and quality of life: the European trial.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Prospective Studies; Quality of Life; Random Allocation | 1985 |
Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications.
Topics: Adult; Aged; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Emotions; Humans; Hypertension; Male; Methyldopa; Middle Aged; Propranolol; Quality of Life; Random Allocation; Sexual Dysfunction, Physiological | 1988 |
Effects of antihypertensive medications on vitality and well-being.
Topics: Adaptation, Psychological; Antihypertensive Agents; Attitude to Health; Captopril; Clinical Trials as Topic; Diuretics; Double-Blind Method; Fatigue; Humans; Hypertension; Male; Methyldopa; Propranolol; Quality of Life; Random Allocation; Time Factors; Work Schedule Tolerance | 1987 |
Serum zinc is unaffected by effective captopril treatment of hypertension.
Topics: Blood Pressure; Captopril; Clinical Trials as Topic; Copper; Double-Blind Method; Humans; Hypertension; Methyldopa; Propranolol; Random Allocation; Taste; Zinc | 1987 |
The effects of antihypertensive therapy on the quality of life.
Topics: Adult; Aged; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Propranolol; Quality of Life; Random Allocation | 1986 |
Clinical trial of captopril (Aceten) in Indian patients with essential hypertension.
Topics: Adult; Aged; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Pulse | 1986 |
Comparative evaluation of captopril and methyldopa monotherapy for hypertension: double-blind study in Indians.
Topics: Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Resistance; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Random Allocation | 1986 |
Antihypertensive therapy and quality of life.
Topics: Antihypertensive Agents; Attitude to Health; Captopril; Clinical Trials as Topic; Humans; Hypertension; Methyldopa; Patient Compliance; Propranolol; Quality of Life | 1987 |
Third-line therapy. A cautionary note.
Topics: Atenolol; Bendroflumethiazide; Captopril; Chlorthalidone; Female; Humans; Hypertension; Male; Methyldopa; Nifedipine | 1985 |
[Multicenter study of the efficacy of 3 antihypertensive regimens: captopril + hydrochlorothiazide, oxprenolol + hydrochlorothiazide, and alphamethyldopa + hydrochlorothiazide].
Topics: Adult; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Prospective Studies; Spain | 1985 |
The efficacy and safety of enalapril in moderate to severe essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Random Allocation; Statistics as Topic | 1984 |
Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide.
Topics: Adult; Arteries; Captopril; Diuretics; Female; Hemodynamics; Humans; Hypertension; Indapamide; Male; Methyldopa; Middle Aged; Proline; Regional Blood Flow; Vascular Resistance | 1984 |
Central effects of repeated administration of atenolol and captopril in healthy volunteers.
Topics: Adult; Atenolol; Attention; Blood Pressure; Captopril; Central Nervous System; Electroencephalography; Flicker Fusion; Heart Rate; Humans; Male; Memory, Short-Term; Mental Recall; Methyldopa; Oxazepam; Psychomotor Performance; Reaction Time | 1994 |
Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Captopril; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Male; Methyldopa; Middle Aged; Quality of Life | 1994 |
A multicenter, double-blind, randomized, placebo-controlled study of isradipine and methyldopa as monotherapy or in combination with captopril in the treatment of hypertension. The LOMIR-MCT-IH Research Group.
Topics: Adult; Captopril; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Male; Methyldopa; Middle Aged; Treatment Outcome | 1993 |
Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Case-Control Studies; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Male; Methyldopa; Middle Aged; Quality of Life; Treatment Outcome | 1996 |
31 other study(ies) available for captopril and methyldopa
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[The physiological basis of the treatment of arterial hypertension].
Topics: Adrenergic beta-Antagonists; Angiotensins; Captopril; Central Nervous System; Clonidine; Humans; Hypertension; Methyldopa; Renin; Reserpine; Saralasin; Sodium | 1979 |
HPLC of urinary catecholamines in the presence of labetalol, captopril, and alpha-methyldopa.
Topics: Adrenal Gland Neoplasms; Captopril; Catecholamines; Chromatography, High Pressure Liquid; False Positive Reactions; Humans; Labetalol; Methyldopa; Pheochromocytoma | 1990 |
Therapy of venous hypertension in calves with total artificial heart (TAH).
Topics: Animals; Antihypertensive Agents; Captopril; Cardiac Pacing, Artificial; Cattle; Central Venous Pressure; Clonidine; Heart, Artificial; Hypertension; Liver Function Tests; Methyldopa; Nifedipine; Postoperative Complications; Prazosin | 1989 |
[Therapy of venous hypertension in animals with an artificial heart and long-term survival].
Topics: Animals; Antihypertensive Agents; Captopril; Cattle; Clonidine; Diltiazem; Heart, Artificial; Methyldopa; Nifedipine; Prazosin; Venous Pressure | 1989 |
[Hypertension in pregnancy: proposed monitoring and therapy].
Topics: Adrenergic beta-Antagonists; Captopril; Diuretics; Female; Follow-Up Studies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular | 1985 |
Historical perspective on the management of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Captopril; Diuretics; History, 20th Century; Humans; Hydralazine; Hypertension; Methyldopa; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; United States | 1986 |
Utility of behavioral science techniques in assessing adverse effects of antihypertensive agents.
Topics: Adult; Antihypertensive Agents; Captopril; Humans; Hypertension; Male; Methyldopa; Middle Aged; Patient Compliance; Propranolol; Quality of Life; Research Design | 1987 |
Cough associated with the use of captopril.
Topics: Aged; Captopril; Carteolol; Cough; Drug Therapy, Combination; Female; Humans; Hypertension; Methyldopa; Proline; Trichlormethiazide | 1985 |
[Ergometric evaluation of effects of captopril in hypertensive patients with exertion-induced angina].
Topics: Aged; Angina Pectoris; Captopril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged | 1985 |
Ergometric evaluation of the effects of captopril in hypertensive patients with stable angina.
Topics: Aged; Angina Pectoris; Captopril; Exercise Test; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged | 1985 |
[The use of vasodilator agents in the therapy of chronic cardiac insufficiency].
Topics: Adrenergic alpha-Antagonists; Calcium Channel Blockers; Captopril; Clonidine; Diuretics; Heart Failure; Humans; Methyldopa; Nitrates; Nitroprusside; Prazosin; Vasodilator Agents | 1982 |
Antihypertensives and their impact on renal function.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Captopril; Central Nervous System; Clonidine; Glomerular Filtration Rate; Humans; Kidney; Labetalol; Methyldopa; Prazosin; Renal Circulation; Vasodilator Agents | 1983 |
Office management of hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Antihypertensive Agents; Benzothiadiazines; Captopril; Clonidine; Diuretics; Guanabenz; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Prazosin; Reserpine; Sodium Chloride Symporter Inhibitors | 1984 |
Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.
Topics: Antihypertensive Agents; Captopril; Clonidine; Guanethidine; Humans; Hydrochlorothiazide; Hypertension; Methyldopa; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Reserpine; Sympathetic Nervous System; Vasodilator Agents | 1984 |
Studies on the mechanism of the synergistic antihypertensive activity of captopril and hydrochlorothiazide following acute administration in spontaneously hypertensive rats.
Topics: Animals; Captopril; Drug Synergism; Drug Therapy, Combination; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Male; Methyldopa; Proline; Rats; Rats, Inbred Strains; Renin | 1982 |
Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
Topics: Actins; Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Blood Pressure; Captopril; Cardiomegaly; DNA; DNA Primers; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Heart; Hydralazine; Hydroxyproline; Imidazoles; Isoproterenol; Labetalol; Losartan; Male; Methyldopa; Molecular Sequence Data; Myocardium; Myosins; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Tetrazoles; Transcription, Genetic | 1994 |
Lack of involvement of the kallikrein-kinin system in the depressor effect of alpha-methyldopa in normotensive rats.
Topics: Animals; Blood Pressure; Bradykinin; Captopril; Chromatography, High Pressure Liquid; Guinea Pigs; Kallikreins; Kininogens; Kinins; Male; Methyldopa; Rats; Rats, Wistar | 1994 |